World ADC Asia is a focused conference that will unite the leaders in the field to identify and discuss the critical factors that will influence the next 12 months of your ADC development.
It is designed with the leading minds from BMS, Takeda and Daiichi Sankyo who will ensure that you will leave with the latest data, science and lessons learned. You’ll also gain critical insight and valuable partnerships to accelerate the development of your ADC drug pipeline and maximize the therapeutic window of your candidate.
Hear from 28 ADC thought leaders from the leading ADC organisations as they discuss:
- Lessons learned on filing a successful IND to regulatory bodies in Asia and effectively translating into the clinic
- Discover novel targets and lower potency payloads to improve the efficacy and safety of your ADC
- Explore novel ADC technologies to enhance your ADC pipeline and maximize the therapeutic index of your ADC candidate
- Discuss the current clinical status and future directions to get an understanding of the ADC landscape to allow you to develop meaningful business partnerships for 2019